The U.S. Government has selected the Institute of Advanced Sciences for a Defense Threat Reduction Agency (DTRA) consortium project supporting the development of small molecule drug candidates against botulism.
DTRA has established a multicenter program in which directed research projects are submitted, evaluated and selected to sponsor a network of collaboration amongst researchers.
In response to this multicenter collaboration, the Institute of Advanced Sciences will support the efforts at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) by performing high throughput screening (HTS) of natural product and small molecule libraries.
The Institute of Advanced Science’s first year of research cost is estimated at $275,044. Total five year cost is $2,876,104.
This consortium type research is under the Memorandum of Agreement (MOA) between DTRA and USAMRICD.